Comparative activities of ciprofloxacin, clinafloxacin, gatifloxacin, gemifloxacin, levofloxacin, moxifloxacin, and trovafloxacin against epidemiologically defined Acinetobacter baumannii strains.

Antimicrobial Agents and Chemotherapy
B HeinemannH Seifert

Abstract

In vitro activities of seven fluoroquinolones against 140 clinical Acinetobacter baumannii isolates representing 138 different strain types were determined. The rank order of activity was clinafloxacin > gatifloxacin > levofloxacin > trovafloxacin > gemifloxacin = moxifloxacin > ciprofloxacin. The 31 outbreak-related A. baumannii strains were significantly more resistant than were 109 sporadic strains.

References

Sep 1, 1987·Annales De L'Institut Pasteur. Microbiology·P J Bouvet, P A Grimont
May 1, 1995·Antimicrobial Agents and Chemotherapy·J VilaT Jimenez de Anta
Jul 1, 1994·Journal of Clinical Microbiology·H SeifertG Pulverer
Aug 1, 1994·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·H SeifertG Pulverer
Nov 1, 1993·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Y Siegman-IgraJ Avram
Apr 1, 1993·Antimicrobial Agents and Chemotherapy·H SeifertG Pulverer
Apr 1, 1996·Clinical Microbiology Reviews·E Bergogne-Bérézin, K J Towner
Jul 1, 1997·The Journal of Antimicrobial Chemotherapy·A PascualE J Perea
Sep 18, 1997·Microbiology and Molecular Biology Reviews : MMBR·K Drlica, X Zhao
Aug 8, 1998·Annals of Internal Medicine·D VillersH Richet
Feb 24, 1999·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·H WisplinghoffH Seifert
Mar 25, 1999·Clinical Therapeutics·J M Blondeau
Jun 29, 1999·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·J RuizJ Gómez
Oct 19, 1999·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·L C McDonaldW R Jarvis
Oct 6, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·H WisplinghoffH Seifert

Citations

Aug 15, 2001·Diagnostic Microbiology and Infectious Disease·E J Giamarellos-BourboulisH Giamarellou
Oct 19, 2002·International Journal of Antimicrobial Agents·Zerrin AktaşOzdem Anğ
Aug 13, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·H WisplinghoffM B Edmond
Jul 25, 2007·Antimicrobial Agents and Chemotherapy·Federico PerezRobert A Bonomo
Jul 16, 2008·Clinical Microbiology Reviews·Anton Y PelegDavid L Paterson
Jan 17, 2008·Drugs·J Gilad, Yehuda Carmeli
May 25, 2004·Expert Opinion on Pharmacotherapy·J M Blondeau, Bayan Missaghi
Oct 3, 2009·Médecine et maladies infectieuses·A Ben Haj Khalifa, M Khedher
May 15, 2007·The Journal of Hospital Infection·H WisplinghoffH Seifert
Jan 7, 2015·International Journal of Antimicrobial Agents·Paola Bocanegra-IbariasElvira Garza-González

Related Concepts

Related Feeds

Allergy & Infectious Diseases (ASM)

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Acinetobacter Infections

Acinetobacter infections have become common in hospitalized patients, especially in the intensive care unit setting and are difficult to treat due to their propensity to develop antimicrobial drug resistance. Discover the latest research on Acinetobacter Infections here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Allergy & Infectious Diseases

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

Related Papers

Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
Philip J TurnerMYSTIC Study Group (Europe)
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
J GiladD Schwartz
© 2021 Meta ULC. All rights reserved